探讨献血者性别对澳大利亚极低出生体重儿结局的影响。

IF 1.6 4区 医学 Q3 HEMATOLOGY
Vox Sanguinis Pub Date : 2025-09-01 Epub Date: 2025-08-03 DOI:10.1111/vox.70065
Georgina Jacko, Aarany Sivakaanthan, Peter Cunningham, James Daly, Helen Liley
{"title":"探讨献血者性别对澳大利亚极低出生体重儿结局的影响。","authors":"Georgina Jacko, Aarany Sivakaanthan, Peter Cunningham, James Daly, Helen Liley","doi":"10.1111/vox.70065","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Despite many known benefits of red blood cell (RBC) transfusions for very low birth weight (VLBW) infants, there is increasing concern that they may be associated with adverse clinical outcomes and that donor characteristics (including donor sex) could contribute to these adverse outcomes.</p><p><strong>Materials and methods: </strong>Outcomes of a 7-year (2016-2022) retrospective cohort of VLBW preterm infants born at Mater Mothers' Hospital who received at least one RBC transfusion and no other blood products were assessed. While adjusting for the number of transfusions administered to each neonate, we investigated the association between donor sex (expressed as the proportion of transfused RBC units collected from female donors) and standardized morbidity outcomes that are reported to the Australian and New Zealand Neonatal Network. These outcomes include bronchopulmonary dysplasia, late onset infection, retinopathy of prematurity and mortality.</p><p><strong>Results: </strong>Analysis including 394 neonates who received a total of 820 RBC transfusions did not identify any statistically significant associations between blood donor sex and the outcomes of interest.</p><p><strong>Conclusion: </strong>Our findings support the continued practice of administration of RBC transfusions to Australian VLBW neonates without consideration of blood donor sex. Further large, prospective, multi-centre studies are recommended to enhance the level of evidence addressing this clinical concern.</p>","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":"921-927"},"PeriodicalIF":1.6000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12422830/pdf/","citationCount":"0","resultStr":"{\"title\":\"Exploring the influence of blood donor sex on outcomes in Australian very low birth weight infants.\",\"authors\":\"Georgina Jacko, Aarany Sivakaanthan, Peter Cunningham, James Daly, Helen Liley\",\"doi\":\"10.1111/vox.70065\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and objectives: </strong>Despite many known benefits of red blood cell (RBC) transfusions for very low birth weight (VLBW) infants, there is increasing concern that they may be associated with adverse clinical outcomes and that donor characteristics (including donor sex) could contribute to these adverse outcomes.</p><p><strong>Materials and methods: </strong>Outcomes of a 7-year (2016-2022) retrospective cohort of VLBW preterm infants born at Mater Mothers' Hospital who received at least one RBC transfusion and no other blood products were assessed. While adjusting for the number of transfusions administered to each neonate, we investigated the association between donor sex (expressed as the proportion of transfused RBC units collected from female donors) and standardized morbidity outcomes that are reported to the Australian and New Zealand Neonatal Network. These outcomes include bronchopulmonary dysplasia, late onset infection, retinopathy of prematurity and mortality.</p><p><strong>Results: </strong>Analysis including 394 neonates who received a total of 820 RBC transfusions did not identify any statistically significant associations between blood donor sex and the outcomes of interest.</p><p><strong>Conclusion: </strong>Our findings support the continued practice of administration of RBC transfusions to Australian VLBW neonates without consideration of blood donor sex. Further large, prospective, multi-centre studies are recommended to enhance the level of evidence addressing this clinical concern.</p>\",\"PeriodicalId\":23631,\"journal\":{\"name\":\"Vox Sanguinis\",\"volume\":\" \",\"pages\":\"921-927\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12422830/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vox Sanguinis\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/vox.70065\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/3 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vox Sanguinis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/vox.70065","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/3 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景和目的:尽管对极低出生体重(VLBW)婴儿输血有许多已知的益处,但越来越多的人担心输血可能与不良临床结果相关,并且供者特征(包括供者性别)可能导致这些不良结果。材料和方法:对在母医院出生的至少接受过一次RBC输血且未接受其他血液制品的VLBW早产儿进行7年(2016-2022)回顾性队列研究的结果进行评估。在调整每个新生儿输血次数的同时,我们调查了供体性别(表示为从女性供体收集的输血红细胞单位的比例)与报告给澳大利亚和新西兰新生儿网络的标准化发病率结果之间的关系。这些结果包括支气管肺发育不良、迟发性感染、早产儿视网膜病变和死亡率。结果:对394名接受820次红细胞输血的新生儿的分析没有发现献血者性别与结果之间有统计学意义的关联。结论:我们的研究结果支持在不考虑献血者性别的情况下继续向澳大利亚VLBW新生儿输注红细胞的做法。建议进一步进行大型、前瞻性、多中心研究,以提高解决这一临床问题的证据水平。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Exploring the influence of blood donor sex on outcomes in Australian very low birth weight infants.

Exploring the influence of blood donor sex on outcomes in Australian very low birth weight infants.

Background and objectives: Despite many known benefits of red blood cell (RBC) transfusions for very low birth weight (VLBW) infants, there is increasing concern that they may be associated with adverse clinical outcomes and that donor characteristics (including donor sex) could contribute to these adverse outcomes.

Materials and methods: Outcomes of a 7-year (2016-2022) retrospective cohort of VLBW preterm infants born at Mater Mothers' Hospital who received at least one RBC transfusion and no other blood products were assessed. While adjusting for the number of transfusions administered to each neonate, we investigated the association between donor sex (expressed as the proportion of transfused RBC units collected from female donors) and standardized morbidity outcomes that are reported to the Australian and New Zealand Neonatal Network. These outcomes include bronchopulmonary dysplasia, late onset infection, retinopathy of prematurity and mortality.

Results: Analysis including 394 neonates who received a total of 820 RBC transfusions did not identify any statistically significant associations between blood donor sex and the outcomes of interest.

Conclusion: Our findings support the continued practice of administration of RBC transfusions to Australian VLBW neonates without consideration of blood donor sex. Further large, prospective, multi-centre studies are recommended to enhance the level of evidence addressing this clinical concern.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Vox Sanguinis
Vox Sanguinis 医学-血液学
CiteScore
4.40
自引率
11.10%
发文量
156
审稿时长
6-12 weeks
期刊介绍: Vox Sanguinis reports on important, novel developments in transfusion medicine. Original papers, reviews and international fora are published on all aspects of blood transfusion and tissue transplantation, comprising five main sections: 1) Transfusion - Transmitted Disease and its Prevention: Identification and epidemiology of infectious agents transmissible by blood; Bacterial contamination of blood components; Donor recruitment and selection methods; Pathogen inactivation. 2) Blood Component Collection and Production: Blood collection methods and devices (including apheresis); Plasma fractionation techniques and plasma derivatives; Preparation of labile blood components; Inventory management; Hematopoietic progenitor cell collection and storage; Collection and storage of tissues; Quality management and good manufacturing practice; Automation and information technology. 3) Transfusion Medicine and New Therapies: Transfusion thresholds and audits; Haemovigilance; Clinical trials regarding appropriate haemotherapy; Non-infectious adverse affects of transfusion; Therapeutic apheresis; Support of transplant patients; Gene therapy and immunotherapy. 4) Immunohaematology and Immunogenetics: Autoimmunity in haematology; Alloimmunity of blood; Pre-transfusion testing; Immunodiagnostics; Immunobiology; Complement in immunohaematology; Blood typing reagents; Genetic markers of blood cells and serum proteins: polymorphisms and function; Genetic markers and disease; Parentage testing and forensic immunohaematology. 5) Cellular Therapy: Cell-based therapies; Stem cell sources; Stem cell processing and storage; Stem cell products; Stem cell plasticity; Regenerative medicine with cells; Cellular immunotherapy; Molecular therapy; Gene therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信